Evaluation the efficacy of narrow band ultraviolet B phototherapy in childhood vitiligo

Authors

  • jamal khadam Tishreen University

Abstract

      Vitiligo is an idiopathic acquired dermatosis characterized by depigmented macules or patches, affects 0.5-2% of the world-wide papulation, and half of the patients suffering onset of the depigmentation prior of the age of 20 years. Narrow band ultraviolet B (NB-UVB) treatment is commonly used of psoriasis and atopic dermatitis, and is less often used for vitiligo in children.

The aim of this study was to evaluate the efficacy and short-term safety of NB-UVB phototherapy in children diagnosed with vitiligo.

Materials and methods: 24 children patients with diagnosis of vitiligo (10 males and 14 females), aged 4-16 years, were treated twice weekly with NB-UVB radiation therapy for a maximum period of one year, and were followed-up for six months for stability of repigmentation. Clinical response was assessed according to repigmentation of the lisions: good response when there was more than 75% repigmentation, moderate when there was 25-75% repigmentation, poor response when repigmentation was 1-24%, and unresponsive when there no repigmentation.

Results: analysis of this study showed that 11(45.8%) of cases had more than 75% to complete repigmentation, 6(25%) achived 25-75% moderate repigmentation, 5(20.8%) had 1-24% mild repigmentation, only 2 (8.4%) of cases did not response to NB-UVB and also 2 cases developed depigmentation of repigmentation sites during 6 months follow-up. Adverse effects were transient and minimal.

Conclusion: NB-UVB therapy is effective and safe tool in the management of childhood vitiligo, with good stability of repigmentation.

 

Downloads

Published

2023-09-13

How to Cite

1.
khadam jamal. Evaluation the efficacy of narrow band ultraviolet B phototherapy in childhood vitiligo. Tuj-hlth [Internet]. 2023Sep.13 [cited 2024Nov.24];45(4):95-102. Available from: https://journal.tishreen.edu.sy/index.php/hlthscnc/article/view/15513

Issue

Vol. 45 No. 4 (2023): Tishreen University Journal for Research and Scientific Studies - Health Sciences Series

Section

Articles

License

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

The authors retain the copyright and grant the right to publish in the magazine for the first time with the transfer of the commercial right to Tishreen University Journal for Research and Scientific Studies - Health Sciences Series

 Under a CC BY- NC-SA 04 license that allows others to share the work with of the work's authorship and initial publication in this journal. Authors can use a copy of their articles in their scientific activity, and on their scientific websites, provided that the place of publication is indicted in  Tishreen University Journal for Research and Scientific Studies - Health Sciences Series   .  The Readers have the right to send, print and subscribe to the initial version of the article, and the title of  Tishreen University Journal for Research and Scientific Studies - Health Sciences Series  Publisher

journal uses a CC BY-NC-SA license which mean

You are free to:

  • Adapt — remix, transform, and build upon the material
  •  
  • The licensor cannot revoke these freedoms as long as you follow the license terms.

 

  • Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
  • NonCommercial — You may not use the material for commercial purposes.
  • ShareAlike — If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.
  • No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.